Your Source for Venture Capital and Private Equity Financings

Stellaromics Secures $25M Series A Financing

2023-11-06
BOSTON, MA, Stellaromics, a leading provider of in situ spatial multi-omics technology, has raised $25 million in a Series A financing round.
The Series A financing round included Plaisance Capital Management and a private family office based in Silicon Valley. Founded in 2022, the company is developing next-generation spatial technology that promises to accelerate the development of fundamentally novel drug treatments, including for autoimmune diseases, cancer, neuropsychiatric disorders, and infectious diseases.

Stellaromics, founded in 2022 and based in Boston, is advancing biomedical research with patented technology that deciphers intricate 3D transcription and translation patterns in native biological tissue. Their flagship product, STARmap (Spatially-resolved Transcript Amplicon Readout mapping), reveals gene expression patterns within intact tissue, aiding in the identification of treatment targets and supporting biomedical research. Stellaromics is in late-stage product development on its Plexa™ suite of products, designed to enable researchers and clinicians to create detailed cellular maps for enhanced disease understanding.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors